Physician profile
Stuart M Tuck
NPI 1649230335
$1,713.10
in general payments reported to CMS, 2019-2025
28 companies · $340 in 2025
The $340 reported for 2025 was more than what a typical Podiatrist provider received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $375 · 2020: $53.23 · 2021: $142 · 2022: $265 · 2023: $427 · 2024: $111 · 2025: $340.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $878.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $878.30 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nevro Corp. | $408.87 | 2022-2023 | Senza |
| Paratek Pharmaceuticals, INC. | $133.65 | 2022-2025 | Nuzyra |
| Mimedx Group, INC. | $131.34 | 2025 | |
| Pacira Pharmaceuticals Incorporated | $127.39 | 2019-2025 | Exparel, Iovera |
| Bioventus LLC | $126.71 | 2019-2021 | |
| Horizon Therapeutics Plc | $123.24 | 2019-2021 | |
| Averitas Pharma INC. | $91.57 | 2023 | Qutenza |
| Smith+Nephew, INC. | $87.46 | 2021-2025 | Grafix Pl |
| Zyla Life Sciences, INC. | $87.05 | 2019 | |
| Zimmer Biomet Holdings, INC. | $37.62 | 2021 | |
| Polynovo North America LLC | $35.64 | 2025 | Novosorb Btm |
| Abbvie INC. | $29.15 | 2023 | Dalvance |
| Ani Pharmaceuticals, INC. | $28.82 | 2024-2025 | Purified Cortrophin Gel |
| Wright Medical Technology, INC. | $26.58 | 2019 | |
| Sebela Pharmaceuticals INC. | $26.29 | 2019 |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kerecis Limited | $24.60 | 2019 | |
| Medtronic, INC. | $22.01 | 2024 | Intellis Adaptivestim |
| Biotronik Nro, INC. | $19.12 | 2025 | |
| Acera Surgical, INC. | $18.14 | 2023 | Restrata Wound Matrix |
| Hydrofera LLC | $17.49 | 2023 | Hydrofera Blue |
| Stryker Corporation | $16.95 | 2021 | |
| Treace Medical Concepts, INC. | $16.45 | 2025 | |
| Axogen | $16.15 | 2020 | |
| Zimvie INC. | $15.28 | 2023 | |
| Integra Lifesciences Corporation | $12.06 | 2019 | |
| Assertio Therapeutics, INC. | $12.02 | 2020 | |
| Abbott Laboratories | $11.55 | 2021 | |
| Reprise Biomedical, INC. | $9.90 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stuart Tuck listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.